Search for: "Lilly France"
Results 41 - 60
of 135
Sorted by Relevance
|
Sort by Date
23 Jan 2012, 11:04 am
In addition, both France and Germany have either banned or placed significant restrictions on the prescription of Actos. [read post]
3 Jan 2012, 5:38 pm
France and Germany pulled pioglitazone-containing medicines from the market in July of 2011. [read post]
4 Jun 2006, 7:22 pm
hansdorf; and Thoraxklinik-Rohrbach, Heidelberg, Germany; Institut Gustave Roussy, Villejuif, France; Royal Prince Alfred Hospital, Camperdown, Australia; and Hacettepe University Medical Faculty, Ankara, Turkey. [read post]
2 Apr 2010, 7:00 am
O hacker concedeu uma entrevista ao site francês Zatazm, onde contou todo o trabalho que teve para conseguir invadir o Twitter. [read post]
15 Apr 2017, 4:17 am
Tune in LIVE for tomorrow's Eli Lilly v Actavis Supreme Court showdownThe Supreme Court was live online to hear Tom Mitcheson QC (supported by Andrew Waugh QC and leading Stuart Baran) for Eli Lilly against Danny Alexander QC (leading Thomas Raphael QC) for Actavis.Oldie but goldie - when is old prior art a suitable starting point for inventive step analysis? [read post]
20 Mar 2020, 4:45 am
Find Parts 1 and 2 here and here.Never Too Late 255 [Week ending March 1] Breaking news: UK will not participate in UPC system | Nothing to see here, Lilly wins in kicking out Genentech's Talz progeny patent (for now) | The Swedish Patent and Market Court of Appeal applies "Abraxis" in rejecting Supplementary Protection Certificate | How do you determine the novelty of a second (non-medical) use claim? [read post]
19 Apr 2015, 4:01 pm
As one might expect, there's a strong cast of knowledgeable speakers, including leading SPC author Christopher Brückner (Stolmár & Partner, Germany), Laëtitia Bénard (Allen & Overy, France) and Edward Oates (Carpmael & Ransford, London). [read post]
10 Feb 2010, 4:47 pm
(Patent Docs) Zyrtec (Cetirizine) - France: Tribunale de Grande Instance finds lack of inventive step: Teva Classics SAS, Teva Sante SASU and Teva Pharmaceutical Industries Ltd v. [read post]
18 May 2011, 12:33 am
Highlights this week included: US: FTC alleges companies were asleep at the wheel when they failed to report settlement agreements on Ambien CR; Commission uses the opportunity to provide industry guidance – and a warning (FDA Law Blog) (GenericsWeb) Gemzar (Gemcitabine) – US: Certiorari denied in Eli Lilly v. [read post]
20 Jul 2011, 4:04 am
– Economic Times reports ‘Letter of Understanding’ between EU and India (Spicy IP) (Generic Pharmaceuticals and IP) France considers paralysing IP rights on the appearance of generic drugs (Class 46) India: Application of Orphan Drug Act to section 3(d)? [read post]
13 Nov 2014, 11:26 am
Under the judge’s ruling, Takeda is responsible for paying $27.6 million in punitive damages and Lilly must pay $9.2 million. [read post]
28 Sep 2011, 1:56 am
(Kluwer Patent Blog) Gabitril (Tiagabine) – US: Cephalon files suits against Sun Pharma. in New Jersey and Michigan in response to Para IV certification (Patent Docs) Glivec (Imatinib) – India: Novartis Glivec patent case: preliminary objection (Spicy IP) Lovenox (Enoxaparin) – US: Momenta files patent infringement complaint against Amphastar in response to impending launch of generic Lovenox (Patent Docs) Lumigan (Bimatoprost) – US: Validity of Allergan Lumigan patents… [read post]
27 Feb 2015, 6:35 am
A federal jury in Lafayette, Louisiana, last year awarded a massive $9 billion in damages against Takeda and Eli Lilly & Co. [read post]
17 Sep 2011, 5:43 am
In response to the European study, both France and Germany have pulled Actos from the market altogether. [read post]
26 Mar 2012, 3:21 am
In 2009, Eli Lilly and Co. shelled out $1.4 billion to settle charges that it marketed Zyprexa to nursing homes, among other health-care providers, as a sleep aid. [read post]
17 May 2021, 12:45 am
The DutchKat taking some timein her box to focus on just one thing - the latest half-year patent review (and her pink jingle ball)Last year the IPKat started a series recapping patent litigation in some of the major patent litigation jurisdictions in Europe (see reports from the Netherlands, Germany and France). [read post]
16 Mar 2011, 3:50 am
Abbott: Federal Circuit struggles to articulate a coherent standard for compliance with the Lilly written description requirement (Holman’s Biotech IP Blog) Lexapro (Escitalopram) – US: CAFC affirms obviousness of Infosint’s patent claims (IPBiz) Lotronex (Alosetron) – US: Prometheus files patent infringement suit against Roxane in response to Para IV challenge (Patent Docs) Pravastatine – Belgium/France: Post-expiry saisie-contrefaçon: Belgium… [read post]
8 Mar 2018, 6:48 am
Following Actavis vs Eli Lilly, is the UK becoming more author-centric? [read post]
20 Feb 2016, 12:30 pm
Higher in Spain than France or Germany. [read post]
13 Oct 2015, 11:42 am
The UPC comes into force after 13 signatories ratify, of which three have to include UK, Germany and France. [read post]
